Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study

Arts & Humanities

• Asthma 100%
• Placebo 86%
• Remission 64%
• Controlled 54%
• Group Differences 26%
• Self-report 23%
• Exit 17%
• Media Effects 15%
• Effect Size 14%
• Depressive Symptoms 14%
• Rating Scales 12%
• Morbidity 11%
• Mortality 9%
• Risk Factors 8%
• Questionnaire 8%

Medicine & Life Sciences

• Citalopram 84%
• Proof of Concept Study 84%
• Major Depressive Disorder 70%
• Asthma 52%
• Placebos 46%
• Depression 44%
• Adrenal Cortex Hormones 23%
• Self Report 17%
• compound A 12 12%
• Equipment and Supplies 11%
• Outpatients 7%
• Morbidity 5%
• Mortality 4%
• Therapeutics 1%

Social Sciences

• Group 13%
• rating scale 11%
• trend 11%
• mortality 9%
• questionnaire 5%